by Rikki Almanza | Oct 7, 2026
The VA’s latest suicide prevention report found that most Veterans who died by suicide in 2024 had not recently received VA healthcare. The report––officially the 2026 National Veteran Suicide Prevention Annual Report––released on Sept. 30. examines national...
by Rikki Almanza | Sep 25, 2026
A hearing-assistance program tested at the VA Greater Los Angeles Healthcare System helped Veterans better communicate with doctors and nurses during emergency room visits. Researchers introduced personal voice amplification devices for Veterans who had difficulty...
by Rikki Almanza | Sep 22, 2026
Younger U.S. Veterans have higher levels of PFAS, commonly known as “forever chemicals,” in their blood than civilians of the same age, according to a new study from researchers at Brown University and Harvard T.H. Chan School of Public Health. The study, published...
by Rikki Almanza | Aug 12, 2026
The VA has launched a clinical trial to study whether psilocybin can safely help Veterans with major depression that has not responded to conventional treatment, including those who also have PTSD. The study was announced Aug. 5 under the name Psilocybin Intervention...
by Rikki Almanza | Aug 3, 2026
The VA has launched a nationwide clinical trial to determine whether a GLP-1 drug can help Veterans reduce harmful alcohol use. Semaglutide is a GLP-1 medication commonly prescribed for type 2 diabetes and obesity. Researchers are studying whether the drug may also...
by Rikki Almanza | Jul 10, 2026
A new survey from RAND shows a clear divide among Veterans on psychedelics, with views changing depending on the substance and how it would be used. The report, “U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences,” estimates that about 4.8...
